StonvexLoading…
StonvexCore line items from QTRX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2023 2023-09-30 |
|---|---|---|---|---|
Revenue | $138.90M | $137.42M | $122.37M | $90.82M |
Operating Income | $-125.54M | $-52.62M | $-45.99M | $-32.37M |
Net Income | $-107.15M | $-38.53M | $-28.35M | $-19.54M |
EPS (Diluted) | $-2.51 | $-1.00 | $-0.75 | $-0.52 |
Total Assets | $418.77M | $406.53M | $428.57M | $429.22M |
Total Liabilities | $123.04M | $76.50M | $78.61M | $76.43M |
Cash & Equivalents | $29.84M | $56.71M | $174.42M | $201.26M |
Free Cash Flow OCF − CapEx | $-79.85M | $-38.53M | $-22.69M | $-14.54M |
Shares Outstanding | 46.74M | 38.57M | 38.01M | 37.84M |